Life Science Intelligence (LSI) has announced a multi-year collaboration with Mednovation, an industry hub for executives, entrepreneurs and investors working to finance and grow medtech ventures in China. Together, Mednovation and LSI will foster innovation and expand support for medtech leaders in the Chinese ecosystem.

As LSI’s preferred partner in China, Mednovation will support LSI events, market intelligence products, research services, and other strategic initiatives in China. Mednovation will continue to support and be integrated into LSI’s marquee Emerging Medtech Summits across North America and Europe, and will support LSI in expanding the Emerging Medtech Summit event family globally.

“China’s ecosystem presents a tremendous opportunity to advance medtech innovation and continue our efforts towards saving patient lives and improving the standard of care globally” said Scott Pantel, CEO of LSI. 

William Jin, Partner at Mednovation said, “The cooperation between our companies will help us best support LSI’s global expansion efforts, medtech leaders that are exploring the Chinese market, medtech leaders in the Chinese market today, and the members of Mednovation seeking to access international markets and resources.”